Fig. 3
From: IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Dynamic changes of coagulation and thrombosis-related indicators in the two outcomes after the critical illness turned into severe and the critically ill patients eventually died. A.1, A.2 Dynamic changes of IP-10: when the critical illness turned into severe, the IP-10 level in most patients increased at first and then decreased along the 20–30 days of the disease. When the critical illness turned into death, the IP-10 level in most patients decreased at first and then increased in approximately 20–30 days of disease progression. B.1, B.2 Dynamic changes of MCP-1: when the critical illness turned into severe, the MCP-1 level gradually decreased in most patients. When the critical illness turned to death, the MCP-1 level gradually increased in most patients. C.1, C.2 Dynamic changes of MIP1α: when the critical illness turned into severe, the MIP1α level gradually decreased in most patients. When the critical illness turned into death, the MIP1α level gradually increased in most patients